
Opinion|Videos|May 29, 2024
Unmet Needs in Relapsed or Refractory Multiple Myeloma
Sarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP-2–Targeted Therapy
2
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
3
FDA Approves First At-Home Treatment Device for Depression
4
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
5




















































































































































































































